Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DOCK8 | Q8NF50 | Dedicator of cytokinesis protein 8 | Disease related genesHuman disease related genesPredicted intracellular proteins | Intellectual disability | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 2 | 0.53 | |||
| EDNRB | P24530 | Endothelin receptor type B (ET-B) (ET-BR) (Endothelin receptor non-selective type) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | AlbinismDeafnessHirschsprung disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.53 | ||
| EFHC1 | Q5JVL4 | EF-hand domain-containing protein 1 (Myoclonin-1) | Disease related genesHuman disease related genesPredicted intracellular proteins | Epilepsy | Other mediation | 2 | 0.53 | |||
| ENOB | P13929 | Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase) | Candidate cardiovascular disease genesDisease related genesEnzymes | Glycogen storage disease | Metabolism mediation | 2 | 0.53 | |||
| EPHB2 | P29323 | Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3) [Cleaved into: EphB2/CTF1; EphB2/CTF2] | Cancer-related genesDisease related genesEnzymes | 1 | Kaposi sarcomaMelanomaPancreatic cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | ||
| EPHB4 | P54760 | Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) | Cancer-related genesDisease related genesEnzymes | 1 | Brain cancerCystic/dysplastic kidney diseaseLung cancer | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.53 | ||
| FAS | P49327 | Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] | Cancer-related genesEnzymesMetabolic proteins | Brain cancerColon cancerconcerning food/fluid intake symptom | Clinical-translation mediationImmune mediationMetabolism mediation | 2 | 0.53 | |||
| FHIT | P49789 | Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein) | Cancer-related genesDisease related genesEnzymes | Nausea/vomiting | Clinical-translation mediation | 2 | 0.53 | |||
| FOLR1 | P15328 | Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18) | Endometrial cancerLung cancerMalaria | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 2 | 0.53 | ||||
| GABR1 | Q9UBS5 | Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1) | FDA approved drug targetsG-protein coupled receptorsPlasma proteins | 7 | Intellectual disability | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.53 |